Schweizerische medizinische Wochenschrift最新文献

筛选
英文 中文
[Polymorphic ventricular tachycardia after intravenous adenosine]. [静脉注射腺苷后多形性室性心动过速]。
R Frank, H Marty
{"title":"[Polymorphic ventricular tachycardia after intravenous adenosine].","authors":"R Frank, H Marty","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":"130 42","pages":"1576"},"PeriodicalIF":0.0,"publicationDate":"2000-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21916782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Volume therapy in hypotensive trauma patients]. [低血压创伤患者的容积治疗]。
H Pargger, W Studer, U Rüttimann
{"title":"[Volume therapy in hypotensive trauma patients].","authors":"H Pargger,&nbsp;W Studer,&nbsp;U Rüttimann","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In trauma patients it is mandatory to establish the exact reason for their hypotension. If hypovolaemia is most probably responsible for the hypotension, fluid resuscitation should be initiated. The therapy of choice is infusion of sugarless, isotonic crystalloids with a physiologic serum electrolyte composition. In patients with brain injuries a decrease in serum osmolality is not advisable and hypertonic fluids may therefore be considered. Human albumin preparations are no longer indicated, but synthetic colloids may be an adjunct to a pure crystalloid regime. Hydroxyethyl starch preparations with a molecular weight in the mean range are reasonable choices considering the individual advantages and disadvantages of the various colloids. Larger blood losses must be treated with blood components such as packed red cells, fresh frozen plasma and thrombocyte concentrates as indicated. There are no widely accepted values for laboratory or monitoring parameters in starting or stopping a given fluid therapy; these values are unquestionably influenced, among other things, by the patient history and the pattern of the injuries. Initial resuscitation (when to start, who should administer the fluid and how much) also remains a focus of heated controversy.</p>","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":"130 42","pages":"1509-15"},"PeriodicalIF":0.0,"publicationDate":"2000-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21917923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical management of acute head injury]. [急性颅脑损伤的临床处理]。
R Stocker, U Bürgi, E Keller, H Imhof
{"title":"[Clinical management of acute head injury].","authors":"R Stocker,&nbsp;U Bürgi,&nbsp;E Keller,&nbsp;H Imhof","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Patients after acute head injury are susceptible to secondary insults and therefore to secondary brain injury. A comprehensive approach, starting at the site of the accident, followed by emergency diagnosis and treatment in the appropriate emergency department of the trauma centre, intensive care and specific neurorehabilitation is the only way to minimise sequelae of primary brain lesions, prevent secondary brain damage and establish optimum frame conditions with respect to recovery from non-definite brain damage.</p>","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":"130 42","pages":"1544-56"},"PeriodicalIF":0.0,"publicationDate":"2000-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21917927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Permissive hypotension. 宽松的低血压。
U Kreimeier, S Prueckner, K Peter
{"title":"Permissive hypotension.","authors":"U Kreimeier,&nbsp;S Prueckner,&nbsp;K Peter","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In trauma patients restoration of intravascular volume in an attempt to achieve normal systemic pressure faces the risk of increasing blood loss and thereby potentially affecting mortality. Due to the lack of controlled clinical trials in this field, the growing evidence that hypotensive resuscitation results in improved long-term survival mainly stems from experimental studies in animals. The main differences between concepts for the reduction of blood loss in systemic hypotension are between \"deliberate hypotension\" (synonym \"controlled hypotension\", used intraoperatively), \"delayed resuscitation\" (where the hypotensive period is intentionally prolonged until operative intervention) and \"permissive hypotension\" (where restrictive fluid therapy increases systemic pressure without reaching normotension). In this review the concept of \"permissive hypotension\" is delineated on the basis of macro- and microcirculatory changes secondary to hypovolaemia and low driving pressure, and the potential indications and limitations are discussed.</p>","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":"130 42","pages":"1516-24"},"PeriodicalIF":0.0,"publicationDate":"2000-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21917924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Invasive candidiasis in critically ill patients]. [危重患者侵袭性念珠菌病]。
P Eggimann, D Pittet
{"title":"[Invasive candidiasis in critically ill patients].","authors":"P Eggimann,&nbsp;D Pittet","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Invasive candidiasis is rare in the general population (about 8 episodes/100,000/year), but has a higher incidence in hospitalised patients (0.5/1000 admissions). It complicates about 10 per 1000 admissions in critical care, where it represents 10-15% of all nosocomial infections. Candidiasis remains difficult to diagnose and its mortality is as high as those of septic shock (40-60%). A better knowledge of the pathophysiology of the disease and the availability of triazole compounds that are less toxic than amphotericin have given rise to the concept of early empirical or preemptive treatment. Prophylaxis of invasive candidiasis, which is very effective, is based on risk factor identification. However, prophylaxis must be restricted to carefully selected groups of patients, to avoid the emergence of resistant strains and a shift in the distribution of pathogens from albicans to non-albicans strains under the pressure of antifungal agents.</p>","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":"130 42","pages":"1525-37"},"PeriodicalIF":0.0,"publicationDate":"2000-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21917925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Tick-borne meningoencephalitis in Thurgau Canton: a clinical and epidiomological analysis]. [图尔高州蜱传脑膜脑炎:临床和流行病学分析]。
M Schwanda, S Oertli, B Frauchiger, M Krause
{"title":"[Tick-borne meningoencephalitis in Thurgau Canton: a clinical and epidiomological analysis].","authors":"M Schwanda,&nbsp;S Oertli,&nbsp;B Frauchiger,&nbsp;M Krause","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Tick-borne meningo-encephalitis (TBE) is caused by a flavivirus species that is transmitted from rodents to humans by Ixodes ticks. The clinical picture of central nervous system involvement varies from febrile headache to lethal encephalitis. To date no specific treatment exists, although protective active immunisation is available.</p><p><strong>Methods: </strong>We present the clinical and epidemiological data from 73 patients with TBE who acquired the infection in Canton Thurgau in the years 1996-1999.</p><p><strong>Results: </strong>Canton Thurgau is a state in eastern Switzerland with a population of 230,000. Within the last five years the reported cases of TBE have increased more than threefold. The area where infectious tick bites were registered has expanded from the western to the eastern part and now encompasses the entire state. The risk of infection is clearly related to frequent activities in wooded areas, though outdoor activities not in forests also carry a considerable risk. In > 80% of the cases a postviral neurasthenic syndrome develops involving absence from work for two months on average. In the elderly and patients who present with encephalitic symptoms, a worse outcome with persistent neurological symptoms or even death has been observed.</p><p><strong>Conclusion: </strong>The increasing incidence of TBE, the expansion of infectious ticks to the east and high morbidity justify active immunisation against TBE on a broad scale in Canton Thurgau.</p>","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":"130 41","pages":"1447-55"},"PeriodicalIF":0.0,"publicationDate":"2000-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21901454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Epidemiology of Lyme borreliosis in French-speaking Switzerland]. [瑞士法语区莱姆病的流行病学]。
I Nahimana, L Gern, O Péter, G Praz, Y Moosmann, P Francioli
{"title":"[Epidemiology of Lyme borreliosis in French-speaking Switzerland].","authors":"I Nahimana,&nbsp;L Gern,&nbsp;O Péter,&nbsp;G Praz,&nbsp;Y Moosmann,&nbsp;P Francioli","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The purpose of this study was to assess the number of cases and the clinical aspects of Lyme borreliosis in French-speaking Switzerland. From July 1996 to December 1997, all laboratories performing serological tests for Lyme borreliosis sent a questionnaire to the treating physicians whenever the tests were positive. In addition, the physicians who diagnosed a case on clinical grounds only were also asked to report these cases. During this period, 1460 positive serological tests were recorded among approximately 10,360 performed (14%). A total of 775 questionnaires were returned (53%). In 3/4 of the cases, the test was ordered because of an acute clinical manifestation or a tick bite. The rest related to chronic symptoms or follow-up. In 504 cases (65%), diagnosis was considered certain or probable. These were erythema migrans in 46%, clinical manifestations of stage II in 33% (26 facial palsy, 20 acute arthritis, 5 benign cutaneous lymphocytoma) and chronic symptoms in 21% (23 acrodermatitis, 26 neuropathies, and 8 arthritis). The adjusted incidence, estimated on the basis of the treating physician's place of residence, ranged from 9/100,000 in Valais to 95/100,000 in Neuchâtel. This study indicates that Lyme borreliosis is a diagnosis frequently looked for and established in French-speaking Switzerland. Although erythema migrans is the main clinical manifestation, symptoms of stage II and III indicate that Lyme borreliosis is also responsible for relatively major systemic morbidity.</p>","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":"130 41","pages":"1456-61"},"PeriodicalIF":0.0,"publicationDate":"2000-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21901455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical epidemiology and research on HIV infection in Switzerland: the Swiss HIV Cohort Study 1988-2000. 瑞士HIV感染的临床流行病学和研究:1988-2000年瑞士HIV队列研究。
P Sudre, M Rickenbach, P Taffé, P Janin, A C Volkart, P Francioli
{"title":"Clinical epidemiology and research on HIV infection in Switzerland: the Swiss HIV Cohort Study 1988-2000.","authors":"P Sudre,&nbsp;M Rickenbach,&nbsp;P Taffé,&nbsp;P Janin,&nbsp;A C Volkart,&nbsp;P Francioli","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background and objectives: </strong>The Swiss HIV Cohort Study (SHCS) was initiated in 1988 and represented the main scientific component of the comprehensive response to the AIDS epidemic in Switzerland. It brought together physicians and scientists from five university hospitals (Basel, Berne, Geneva, Lausanne and Zurich) and two Cantonal hospitals (Lugano and St. Gallen). The objective of SHCS was, and still is, to produce rapid, high quality patient-oriented medical research in the field of HIV infection.</p><p><strong>Methods: </strong>SHCS is a prospective population-based cohort study. Any HIV-infected person aged > or = 16 years is eligible to participate. Data collection and study procedures are standardised. Data quality and protocol monitoring are conducted at the coordination and data centre in Lausanne. Detailed information on demographics, income, mode of HIV acquisition, risk behaviours, clinical events, laboratory results, treatment and treatment tolerance is collected at registration and at 6-monthly intervals.</p><p><strong>Results: </strong>Since 1996, 10,600 persons have been enrolled and the SHCS study population is considered fairly representative of the HIV-infected population in Switzerland, at least in terms of gender and mode of HIV acquisition. In 1999, 4600 patients were actively followed up and more than 70% of patients were receiving highly active antiretroviral therapy (HAART). As a consequence, mortality and the incidence of HIV-related opportunistic infections have decreased significantly in the recent past. Between 1996 and 2000, 91 original manuscripts have been published by SHCS scientists and physicians, almost exclusively in peer-reviewed journals. A wide range of scientific questions have been addressed, including HIV primary infection, the natural history of HIV infection, the clinical and biological impact of HAART, drug resistance, risk factors for disease evolution including the timing of treatment initiation, the role of CD4 receptors, the validity of HIV surveillance reports, determinants of treatment access and tolerance, clinical trials of new drug combinations, the interruption of prophylaxis following a favourable response to HAART and issues relating to quality of life and interaction between income, social level and disease evolution.</p><p><strong>Conclusion: </strong>The SHCS has had, and continues to have, a significant impact on medical practice, public health and research in Switzerland and beyond. It represents a network of excellence which has brought together and fostered intensive collaboration between physicians and institutions throughout this country and beyond. This was possible thanks to the support of the Federal Office of Public Health and the commitment of primary care physicians, researchers and patients. This project may be model for focused and prioritised multicentre and transdisciplinary research programmes.</p>","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":"130 41","pages":"1493-500"},"PeriodicalIF":0.0,"publicationDate":"2000-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21901460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Giant, isolated aneurysms of the common iliac artery]. [髂总动脉巨大的孤立动脉瘤]。
S Korsakas, T Chatterjee, P U Reber, G Bockisch, M Birrer
{"title":"[Giant, isolated aneurysms of the common iliac artery].","authors":"S Korsakas,&nbsp;T Chatterjee,&nbsp;P U Reber,&nbsp;G Bockisch,&nbsp;M Birrer","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":"130 41","pages":"1501"},"PeriodicalIF":0.0,"publicationDate":"2000-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21901461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Infectious diseases in Switzerland at the dawn of the 21st Century]. [21世纪初瑞士的传染病]。
D Lew
{"title":"[Infectious diseases in Switzerland at the dawn of the 21st Century].","authors":"D Lew","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":"130 41","pages":"1433-6"},"PeriodicalIF":0.0,"publicationDate":"2000-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21901452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信